Univariate and multivariate analyses were all revealed CCND3 expression was associated with higher risk of recurrence, which suggested Cyclin D3 might be an independent prognostic factor for breast cancer patients.11 In our meta‐analysis, positive‐CCND3 is associated with reduced OS in breast cancer patients. Here, CCND3 is linked to breast carcinoma.